“…Although t h e field of genetic toxicology had its origins in studies on submammalian species [Brusick, 19801, mammalian and microbial species have become the mainstay of the short-term i n vitro mutagenicity tests that have been extensively developed and widely used to measure t h e mutagenic potential of a wide range of agents. Promi-nent among these are the Salmonella mutagen assay developed by Ames et a1 [1975], tests to detect chromosomal macrolesions such as sister chromatid exchange (SCE) [Latt, 1974;Stetka and Wolff, 1976a,b;Latt et al, 1977;Kligerman, 19791, micronucleus formation [Schmid, 1976;Maier and Schmid, 19761, and chromosomal aberrations [Ziemba-Zoltowska et al, 1980;Edwards et al, 1980;Tsuda, 1981;van Kesterenvan Leeuwen and Natarajan, 19801, as well as tests to detect microlesions such as DNA repair [Lieberman et al, 1971a,b;Viceps-Madore and Mezger-Freed, 19781 and direct cellular mutagenesis [Mankovitz et al, 1974;Arlett et al, 1975;Chinchar and Sinclair, 1978;Jacobs and DeMars, 19781. Since each procedure has its advantages and weak points, it has been suggested that a battery of tests be used to evaluate the mutagenic potential of substances [Nichols et al, 1977;Sobels, 19771. Since chromosomes can be examined in any living system that is undergoing mitosis or meiosis, this type of procedure can be used with embryos, regenerating tissue, lymphocytes, or cell culture.…”